A61K36/70

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
20230095383 · 2023-03-30 ·

Nutraceutical compositions and methods of their use in treating Caliciviridae family viruses are provided. The viruses can be norovirus or sapovirus. An exemplary nutraceutical composition includes Fagopyrum dibotyo extract. Another nutraceutical composition for treating viral gastroenteritis includes 5, 7, 3′, 4′-tetrahydroxyflavan-3-ol C.sub.4-C.sub.8 dimers, quercetin, rutin, or a combination thereof. The nutraceutical compositions inhibit or reduce entry of Caliciviridae family viruses into intestinal epithelial cells of the subject.

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
20230095383 · 2023-03-30 ·

Nutraceutical compositions and methods of their use in treating Caliciviridae family viruses are provided. The viruses can be norovirus or sapovirus. An exemplary nutraceutical composition includes Fagopyrum dibotyo extract. Another nutraceutical composition for treating viral gastroenteritis includes 5, 7, 3′, 4′-tetrahydroxyflavan-3-ol C.sub.4-C.sub.8 dimers, quercetin, rutin, or a combination thereof. The nutraceutical compositions inhibit or reduce entry of Caliciviridae family viruses into intestinal epithelial cells of the subject.

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
20230095383 · 2023-03-30 ·

Nutraceutical compositions and methods of their use in treating Caliciviridae family viruses are provided. The viruses can be norovirus or sapovirus. An exemplary nutraceutical composition includes Fagopyrum dibotyo extract. Another nutraceutical composition for treating viral gastroenteritis includes 5, 7, 3′, 4′-tetrahydroxyflavan-3-ol C.sub.4-C.sub.8 dimers, quercetin, rutin, or a combination thereof. The nutraceutical compositions inhibit or reduce entry of Caliciviridae family viruses into intestinal epithelial cells of the subject.

SUBSTANCE DELIVERY MASK
20230125408 · 2023-04-27 ·

A substance delivery mask includes a body, an exhaling valve, an inhaled valve, and a fog module. The fog module comprises a controlling module, a container, and an atomizer. The controlling module is disposed on the body. The container is disposed on the controlling module, the container is storing a mixed liquid, and the mixed liquid includes water and a plurality of nanoparticles. The atomizer is disposed on the container, the atomizer is used to atomize the water of the mixed liquid to form fog particles, and the fog particles are wrapped several of the nanoparticles respectively. The substance delivery mask can encapsulate the water-soluble or water-insoluble medicines, or nutritional products in the fog particles generated from the atomizer. The present invention can deliver medicine, nutritional products or vaccines by inhalation or oral.

METHOD FOR TREATING HIV/AIDS COMPLICATIONS SUCH AS VIRAL ENCEPHALOPATHY, DRUG-INDUCED ENCEPHALOPATHY, AND NEUROLOGICAL DISORDERS OF IMMUNOCOMPROMISED CONCURRENT OPPORTUNISTIC INFECTIONS INCLUDING MOTOR NERVE, SENSORY NERVE AND OPTIC NERVE DISORDERS
20230141424 · 2023-05-11 ·

The present invention relates to a method for treating HIV/AIDS complications including administering a first Chinese herbal medicine composition to a subject in need; wherein the first Chinese herbal medicine composition is an extract of a first mixture including Polygonatum sibiricum, Astragalus membranaceus, Panax ginseng, Liriope spicata, Schisandra chinensis, Ziziphus zizyphus, Cornus officinalis, Fallopia multiflora, and Salvia miltiorrhiza.

METHOD FOR TREATING HIV/AIDS COMPLICATIONS SUCH AS VIRAL ENCEPHALOPATHY, DRUG-INDUCED ENCEPHALOPATHY, AND NEUROLOGICAL DISORDERS OF IMMUNOCOMPROMISED CONCURRENT OPPORTUNISTIC INFECTIONS INCLUDING MOTOR NERVE, SENSORY NERVE AND OPTIC NERVE DISORDERS
20230141424 · 2023-05-11 ·

The present invention relates to a method for treating HIV/AIDS complications including administering a first Chinese herbal medicine composition to a subject in need; wherein the first Chinese herbal medicine composition is an extract of a first mixture including Polygonatum sibiricum, Astragalus membranaceus, Panax ginseng, Liriope spicata, Schisandra chinensis, Ziziphus zizyphus, Cornus officinalis, Fallopia multiflora, and Salvia miltiorrhiza.

METHOD FOR TREATING HIV/AIDS COMPLICATIONS SUCH AS VIRAL ENCEPHALOPATHY, DRUG-INDUCED ENCEPHALOPATHY, AND NEUROLOGICAL DISORDERS OF IMMUNOCOMPROMISED CONCURRENT OPPORTUNISTIC INFECTIONS INCLUDING MOTOR NERVE, SENSORY NERVE AND OPTIC NERVE DISORDERS
20230141424 · 2023-05-11 ·

The present invention relates to a method for treating HIV/AIDS complications including administering a first Chinese herbal medicine composition to a subject in need; wherein the first Chinese herbal medicine composition is an extract of a first mixture including Polygonatum sibiricum, Astragalus membranaceus, Panax ginseng, Liriope spicata, Schisandra chinensis, Ziziphus zizyphus, Cornus officinalis, Fallopia multiflora, and Salvia miltiorrhiza.

COMPOSITION FOR LYMPH DRAINAGE
20170340692 · 2017-11-30 ·

The present invention relates to a mixture of active ingredients consisting of Taraxacum officinalis, Fagopyrum esculentum, Ruscus aculeatus, Solidago virgaurea and Orthosiphon stamineus or extracts of said plants or from said plants and extracts thereof, a composition comprising such a mixture, and uses thereof.

COMPOSITION FOR LYMPH DRAINAGE
20170340692 · 2017-11-30 ·

The present invention relates to a mixture of active ingredients consisting of Taraxacum officinalis, Fagopyrum esculentum, Ruscus aculeatus, Solidago virgaurea and Orthosiphon stamineus or extracts of said plants or from said plants and extracts thereof, a composition comprising such a mixture, and uses thereof.

PHARMACEUTICAL COMPOSITION AND THE USE THEREOF
20170304381 · 2017-10-26 ·

A pharmaceutical composition, as well as the use of composition in medical applications, are described.